A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
Blue light sources have been shown to be effective in the treatment of mild to moderate inflammatory acne vulgaris lesions. We evaluated the safety and efficacy of a new blue light source in the treatment of mild to moderate inflammatory acne vulgaris in comparison to topical 1% clindamycin solution. Blue light therapy reduced inflammatory acne vulgaris lesions by an average of 34%, as compared to 14% for topical 1% clindamycin solution. The blue light source presented in this report is a safe and effective treatment option available to our patients with mild to moderate inflammatory acne lesions.